PEOPLE - Bacchus Vascular makes appointment:
This article was originally published in Clinica
Executive Summary
Scott Cramer has been promoted to president and CEO of Bacchus Vascular, a Santa Clara, California-based firm focused on devices for the minimally-invasive removal of blood clots. Mr Cramer replaces Scott Rader who is leaving to pursue other business opportunities, though he will remain on the board of directors. Mr Cramer, who joined the firm this year as senior vice-president of sales, has served with several established firms in the field, including VNUS Medical Technologies (senior vice-president, sales/account services) and Baxter Healthcare's cardiovascular division (management position).
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.